Conclusion

The amount of information on tumor necrosis factor has increased tremendously in the past hundred years of research. As we close out this century, the future of TNF research promises to be exciting. Currently, TNF is being studied for experimental cancer immunotherapy. This cytokine is injected into patients and the TNF gene is also a target of gene therapy.

I have had my own personal research with TNF, actually its receptor. In Chem 455, Applications of Biochemical Istrumentation, (at UW--Eau Claire) I have helped synthesize a nine amino acid peptide which has homology in amino acid type to residues in Domain 2 of TNF-R55. This peptide, TASENHLRH, may be used in another project here to bind to a cytomegalovirus protein which is homologous to TNF. Just as this was my first peptide synthesis, the creation of this web page was also a first. Hope you have enjoyed the journey through my pages and have learned something in the process!

Title page.

References.

sarauehl@uwec.edu